Eisai Co., Ltd. ADR (ESALF)
Information Meeting 2019 Conference Call
March 08, 2019 02:00 AM ET
Company Participants
Haruo Naito - Representative Corporate Officer and CEO
Hiroyuki Kobayashi - Medical Division
Ryohei Yanagi - CFO
Ivan Cheung - SVP, President of Neurology Business Group
Dr. Takashi Owa - VP and Chief Medicine Creation Officer & Chief Discovery Officer of Oncology Business
Masanori Tsuno - Deputy Chief Clinical Officer of Neurology Business
Teiji Kimura - Vice President, Chief Discovery Officer, Neurology Business Group
Conference Call Participants
Kazuaki Hashiguchi - Daiwa Securities
Hidemaru Yamaguchi - Citigroup
Motoya